Literature DB >> 25903125

The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency.

Satyaki Sengupta1, Raj Lingnurkar2, Timothy S Carey2, Monica Pomaville2, Parimal Kar2, Michael Feig2, Catherine A Wilson3, Jason G Knott4, David N Arnosti5, R William Henry6.   

Abstract

The retinoblastoma (RB) tumor suppressor and related family of proteins play critical roles in development through their regulation of genes involved in cell fate. Multiple regulatory pathways impact RB function, including the ubiquitin-proteasome system with deregulated RB destruction frequently associated with pathogenesis. With the current study we explored the mechanisms connecting proteasome-mediated turnover of the RB family to the regulation of repressor activity. We find that steady state levels of all RB family members, RB, p107, and p130, were diminished during embryonic stem cell differentiation concomitant with their target gene acquisition. Proteasome-dependent turnover of the RB family is mediated by distinct and autonomously acting instability elements (IE) located in their C-terminal regulatory domains in a process that is sensitive to cyclin-dependent kinase (CDK4) perturbation. The IE regions include motifs that contribute to E2F-DP transcription factor interaction, and consistently, p107 and p130 repressor potency was reduced by IE deletion. The juxtaposition of degron sequences and E2F interaction motifs appears to be a conserved feature across the RB family, suggesting the potential for repressor ubiquitination and specific target gene regulation. These findings establish a mechanistic link between regulation of RB family repressor potency and the ubiquitin-proteasome system.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  retinoblastoma, RB, p107, p130, E2F-DP, cyclin, CDK, protein stability, proteasome, degron, transcriptional repression.

Mesh:

Substances:

Year:  2015        PMID: 25903125      PMCID: PMC4505513          DOI: 10.1074/jbc.M114.599993

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Effects of an Rb mutation in the mouse.

Authors:  T Jacks; A Fazeli; E M Schmitt; R T Bronson; M A Goodell; R A Weinberg
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

2.  Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice.

Authors:  Itsuki Ajioka; Rodrigo A P Martins; Ildar T Bayazitov; Stacy Donovan; Dianna A Johnson; Sharon Frase; Samantha A Cicero; Kelli Boyd; Stanislav S Zakharenko; Michael A Dyer
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

3.  Characterization of an E2F1-specific binding domain in pRB and its implications for apoptotic regulation.

Authors:  L M Julian; O Palander; L A Seifried; J E G Foster; F A Dick
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

4.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

5.  Cyclin-dependent kinase 2-associating protein 1 commits murine embryonic stem cell differentiation through retinoblastoma protein regulation.

Authors:  Yong Kim; Amit Deshpande; Yanshan Dai; Jeffrey J Kim; Anne Lindgren; Anne Conway; Amander T Clark; David T Wong
Journal:  J Biol Chem       Date:  2009-06-29       Impact factor: 5.157

6.  Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence.

Authors:  Agustin Chicas; Xiaowo Wang; Chaolin Zhang; Mila McCurrach; Zhen Zhao; Ozlem Mert; Ross A Dickins; Masashi Narita; Michael Zhang; Scott W Lowe
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

7.  Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters.

Authors:  Kristy R Stengel; Chellappagounder Thangavel; David A Solomon; Steve P Angus; Yi Zheng; Erik S Knudsen
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

8.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 9.  Cellular mechanisms of tumour suppression by the retinoblastoma gene.

Authors:  Deborah L Burkhart; Julien Sage
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

10.  Proapoptotic function of the retinoblastoma tumor suppressor protein.

Authors:  Alessandra Ianari; Tiziana Natale; Eliezer Calo; Elisabetta Ferretti; Edoardo Alesse; Isabella Screpanti; Kevin Haigis; Alberto Gulino; Jacqueline A Lees
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

View more
  4 in total

1.  Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.

Authors:  Tyler J Liban; Edgar M Medina; Sarvind Tripathi; Satyaki Sengupta; R William Henry; Nicolas E Buchler; Seth M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

2.  Diversification of Retinoblastoma Protein Function Associated with Cis and Trans Adaptations.

Authors:  Rima Mouawad; Jaideep Prasad; Dominic Thorley; Pamela Himadewi; Dhruva Kadiyala; Nathan Wilson; Philipp Kapranov; David N Arnosti
Journal:  Mol Biol Evol       Date:  2019-12-01       Impact factor: 16.240

3.  Regulation of cell polarity determinants by the Retinoblastoma tumor suppressor protein.

Authors:  Sandhya Payankaulam; Kelvin Yeung; Helen McNeill; R William Henry; David N Arnosti
Journal:  Sci Rep       Date:  2016-03-14       Impact factor: 4.379

4.  NO1, a New Sigma 2 Receptor/TMEM97 Fluorescent Ligand, Downregulates SOCE and Promotes Apoptosis in the Triple Negative Breast Cancer Cell Lines.

Authors:  Carlos Cantonero; Pedro Javier Camello; Carmen Abate; Francesco Berardi; Gines Maria Salido; Juan Antonio Rosado; Pedro C Redondo
Journal:  Cancers (Basel)       Date:  2020-01-21       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.